The Pharmacokinetics and Safety of Onartuzumab (MetMAb) in Chinese Patients With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT02031731 · COMPLETED
Trial details
- NCT number
- NCT02031731
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-13
- Primary completion
- 2014-04-14
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.